Drug Description in Trials / DrugBank / KEGG DRUG
Search results
Showing 1 to 2 of 2 descriptions
| No. | 薬物名（臨床試験情報から抽出） | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | 指定難病告示番号 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Observational study with patients treated with Tracleer, Ventavis, Veletri, Opsumit and/or Uptravi | 4件: Epoprostenol Epoprostenol (Veletri),Iloprost, Macitentan, Selexipag | 4件: Epoprostenol
Epoprostenol
,Iloprost , Selexipag , Macitentan 💬 1. Observational study with patients treated with Tracleer, Ventavis, Veletri, Opsumit and/or Uptravi
| 3件: EDNRA EDNRA,EDNRB, PTGIR 💬 | 10件: Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Platelet activation, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 10件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in ... | 1件: 86 86 💬1. Observational study with patients treated with Tracleer, Ventavis, Veletri, Opsumit and/or Uptravi
| ||||||||||||||||
| 2 | Veletri | 1件: Epoprostenol Epoprostenol (Veletri) | 1件: Epoprostenol
Epoprostenol
💬2. Veletri
| 1件: PTGIR PTGIR 💬2. Veletri
| 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction ... | 1件: 86 86 💬2. Veletri
|